相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma
Jianfeng Guo et al.
MOLECULAR CANCER (2021)
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
Seyed Hossein Kiaie et al.
ACTA PHARMACEUTICA SINICA B (2021)
Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
Cynthia Aslan et al.
BMC BIOTECHNOLOGY (2021)
Immune checkpoint inhibition for the treatment of renal cell carcinoma
Viktoria Stuehler et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
Hadi Hassannia et al.
IMMUNOLOGY (2020)
Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy
Jihoon Kim et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy
Xia Dong et al.
BIOMATERIALS (2020)
Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer
Sevda Jafari et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
Lindsay M. Scheetz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy
Dandan Wan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-Delivery of Paclitaxel and Interleukin-12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
Qian Hu et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
Somayeh Mahdinloo et al.
ACTA PHARMACEUTICA SINICA B (2020)
Thermosensitive Exosome-Liposome Hybrid Nanoparticle-Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
Qijun Lv et al.
ADVANCED SCIENCE (2020)
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Jackie E. Bader et al.
MOLECULAR CELL (2020)
First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress
Zhangfeng Huang et al.
FRONTIERS IN PHARMACOLOGY (2020)
A Review of Mesoporous Silica Nanoparticle Delivery Systems in Chemo-Based Combination Cancer Therapies
Ying Gao et al.
FRONTIERS IN CHEMISTRY (2020)
Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
Mouldy Sioud
RNA INTERFERENCE AND CRISPR TECHNOLOGIES: TECHNICAL ADVANCES AND NEW THERAPEUTIC OPPORTUNITIES (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Disruption of CTLA-4 expression on peripheral blood CD8+T cell enhances anti-tumor efficacy in bladder cancer
Wei Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
Anubhab Mukherjee et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
Elizabeth I. Buchbinder et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
Quoc-Viet Le et al.
AAPS JOURNAL (2019)
Augmenting the synergies of chemotherapy and immunotherapy through drug delivery
Jihoon Kim et al.
ACTA BIOMATERIALIA (2019)
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Qiuhua Luo et al.
CANCER LETTERS (2019)
Advances in cancer immunotherapy 2019-latest trends
Stephan Kruger et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Immunostimulatory cytokine and doxorubicin co-loaded nanovesicles for cancer immunochemotherapy
Tingting Wu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Modular Engineering of Targeted Dual-Drug Nanoassemblies for Cancer Chemoimmunotherapy
Tianyi Kang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Inorganic Nanozyme with Combined Self-Oxygenation/Degradable Capabilities for Sensitized Cancer Immunochemotherapy
Jie Wang et al.
NANO-MICRO LETTERS (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers
Lv Chen et al.
ADVANCED MATERIALS (2019)
Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy
Xiao Wei et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
Man Li et al.
AAPS JOURNAL (2019)
Cocktail Strategy Based on Spatio-Temporally Controlled Nano Device Improves Therapy of Breast Cancer
Tianqun Lang et al.
ADVANCED MATERIALS (2019)
Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment
Zuhong Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
Mei Gao et al.
BRITISH JOURNAL OF CANCER (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy
Huu Thuy Trang Duong et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy
Haishi Qiao et al.
BIOMATERIALS SCIENCE (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
An immuno-potentiating vehicle made of mesoporous silica-zinc oxide micro-rosettes with enhanced doxorubicin loading for combined chemoimmunotherapy
Guowen Qian et al.
CHEMICAL COMMUNICATIONS (2019)
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
Candido G. Da Silva et al.
THERANOSTICS (2019)
Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy
Ying Hu et al.
NANOSCALE (2019)
Innovative approaches for cancer treatment: current perspectives and new challenges
Carlotta Pucci et al.
ECANCERMEDICALSCIENCE (2019)
Review of cancer treatment with immune checkpoint inhibitors
Christiane Thallinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2018)
Cytokines in Cancer Immunotherapy
Thomas A. Waldmann
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel
Honglin Jin et al.
ACS NANO (2018)
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
Fangxuan Li et al.
CANCER BIOLOGY & THERAPY (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects
Yongdan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy
Yijia Yin et al.
MOLECULAR PHARMACEUTICS (2018)
Entrapping multifunctional dendritic nanoparticles into a hydrogel for local therapeutic delivery and synergetic immunochemotherapy
Lei Jiang et al.
NANO RESEARCH (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophagemediated immunotherapy
Pengfei Zhao et al.
CHEMICAL SCIENCE (2018)
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody-Trastuzumab: The New Approach of a Well-Known Strategy
Monika Marcinkowska et al.
POLYMERS (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Immunotherapies: Exploiting the Immune System for Cancer Treatment
Jeffrey Koury et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach
Danielle Krijgsman et al.
FRONTIERS IN IMMUNOLOGY (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
Taku Fujimura et al.
FRONTIERS IN ONCOLOGY (2018)
Plug-and-Play Nanorization of Coarse Black Phosphorus for Targeted Chemo-photoimmunotherapy of Colorectal Cancer
Wenquan Ou et al.
ACS NANO (2018)
Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency
Yue Han et al.
BIOMATERIALS (2018)
Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
Zili Gu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Enhanced chemo-immunotherapy against melanoma by inhibition of cholesterol esterification in CD8+ T cells
Man Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
被撤回的出版物: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway (Retracted article. See vol. 15, pg. 10735, 2021)
Jianqin Lu et al.
ACS NANO (2018)
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
Yixin Zhou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment
Qiang Lv et al.
BIOACTIVE MATERIALS (2018)
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Kai Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy
Xilong Wu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
Qingle Song et al.
NANO LETTERS (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Doxorubicin Hydrochloride Loaded Zymosan-Polyethylenimine Biopolymeric Nanoparticles for Dual 'Chemoimmunotherapeutic' Intervention in Breast Cancer
Vivek K. Pawar et al.
PHARMACEUTICAL RESEARCH (2017)
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Jason Lohmueller et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer
Kenji Gonda et al.
ONCOLOGY LETTERS (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
Miao Kong et al.
THERANOSTICS (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Natural Killer T Cells in Cancer immunotherapy
Shiny Nair et al.
FRONTIERS IN IMMUNOLOGY (2017)
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment
David H. Munn et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Combination antitumor therapy with targeted dual-nanomedicines
Wenbing Dai et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet
Gabriele D'Errico et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy
Jingjing Wu et al.
ACTA BIOMATERIALIA (2017)
Co-delivery of chemotherapeutics and proteins for synergistic therapy
Chaoliang He et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Combinatorial prospects of nano-targeted chemoimmunotherapy
C. G. Da Silva et al.
BIOMATERIALS (2016)
Current Challenges in Cancer Treatment
Jon Zugazagoitia et al.
CLINICAL THERAPEUTICS (2016)
Chemotherapy and immunotherapy: mapping the road ahead
Alistair M. Cook et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions
Najib Aziz et al.
CYTOKINE (2016)
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer
Hilary Shmeeda et al.
JOURNAL OF DRUG TARGETING (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Yichao Chen et al.
NATURE COMMUNICATIONS (2016)
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Nanogel-Incorporated Physical and Chemical Hybrid Gels for Highly Effective Chemo-Protein Combination Therapy
Xilong Wu et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
L. Apetoh et al.
ANNALS OF ONCOLOGY (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Active Immunotherapy of Cancer
Thinle Chodon et al.
IMMUNOLOGICAL INVESTIGATIONS (2015)
Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab
Pengkai Ma et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Nanoparticu late STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C. Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Engineering opportunities in cancer immunotherapy
Laura Jeanbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy
Kelly Kersten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Furin-Mediated Sequential Delivery of Anticancer Cytokine and Small-Molecule Drug Shuttled by Graphene
Tianyue Jiang et al.
ADVANCED MATERIALS (2015)
Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy
Anushree Seth et al.
BIOMATERIALS (2014)
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Qiong Wu et al.
CANCER LETTERS (2014)
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
H. Inoue et al.
CELL DEATH AND DIFFERENTIATION (2014)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Single-Step Assembly of DOX/ICG Loaded Lipid-Polymer Nanoparticles for Highly Effective Chemo-photothermal Combination Therapy
Mingbin Zheng et al.
ACS NANO (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Dose-Dense Chemotherapy Improves Mechanisms of Antitumor Immune Response
Chih-Long Chang et al.
CANCER RESEARCH (2013)
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
Mariana S. Nars et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
Aniruddha Roy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Particle-mediated delivery of cytokines for immunotherapy
David A. Christian et al.
IMMUNOTHERAPY (2012)
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Tillmann Michels et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Anticancer and Immunostimulatory Activity by Conjugate of Paclitaxel and Non-toxic Derivative of LPS for Combined Chemo-immunotherapy
Aniruddha Roy et al.
PHARMACEUTICAL RESEARCH (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice
Makiya Nishikawa et al.
BIOMATERIALS (2011)
Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates
In-Hyun Lee et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know
Steven A. Rosenberg
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Analysis of anticancer drugs: A review
Susanne Nussbaumer et al.
TALANTA (2011)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A poly(γ-glutamic acid)-amphiphile complex as a novel nanovehicle for drug delivery system
Tetsuyuki Akao et al.
JOURNAL OF DRUG TARGETING (2010)
Combined Chemo-immunotherapy as a Prospective Strategy To Combat Cancer: A Nanoparticle Based Approach
Aniruddha Roy et al.
MOLECULAR PHARMACEUTICS (2010)
Nanoparticle-assisted combination therapies for effective cancer treatment
Che-Ming Jack Hu et al.
THERAPEUTIC DELIVERY (2010)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to Vα24+ NKT cell-mediated cytotoxicity
Stephen R. Mattarollo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice
Andrew Ewens et al.
CANCER RESEARCH (2006)
Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
HL Neville-Webbe et al.
TUMOR BIOLOGY (2006)
Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid
A Ullén et al.
ACTA ONCOLOGICA (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
The T cell as a bridge between innate and adaptive immune systems: Implications for the kidney
H Rabb
KIDNEY INTERNATIONAL (2002)
Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer
GG Gomez et al.
CANCER TREATMENT REVIEWS (2001)
分享论文
